Since secondary bile acids act as ligands for TGR5 and other bile receptors with anti-inflammatory and protective properties (discussed later), this reduction could then aggravate the immune dysfunction seen in IBD patients. Here, GPBAR1 is linked to irritable bowel syndrome.